Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II) [EARLY_Phase 1]
Feasibility study of Suizenji in unresectable pancreatic ductal adenocarcinoma (SUNRISE-II) is an early-phase trial currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations [Phase 1]
Phase 1 study to evaluate ALTA3263 in adults with KRAS-mutant advanced solid tumors, including pancreatic ductal adenocarcinoma, non-small c…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 1]
A Phase 1 clinical trial of PTM-101 for pancreatic ductal adenocarcinoma and related locally advanced or borderline resectable disease is cu…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study to Test KISIMA-02 Vaccine-based Immunotherapy and Ezabenlimab in People With Pancreatic Cancer [Phase 1]
Phase 1 study evaluating Boehringer Ingelheim's KISIMA-02 vaccine-based immunotherapy in combination with ezabenlimab for pancreatic ductal …
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
This clinical trial update outlines the Pancreas Interception Center (PIC) focused on early detection, prevention, and novel therapeutics fo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors [Phase 1, Phase 2]
Revolution Medicines is conducting a Phase 1/2 clinical trial of RAS(ON) inhibitors in gastrointestinal solid tumors, including colorectal c…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]
Phase 3 trial evaluating Quemliclustat in combination with chemotherapy versus placebo with chemotherapy for metastatic pancreatic ductal ad…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours [Phase 1, Phase 2]
Ipsen is conducting a Phase 1/2 trial of IPN01194 as a single-agent therapy for adults with advanced solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating BMS-986504 plus nab-paclitaxel and gemcitabine versus placebo plus nab-paclitaxel and gemcitabine in u…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC
An exploratory clinical evaluation using personalized functional profiling to predict drug response in colorectal cancer and pancreatic duct…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating ONT01 in combination with gemcitabine and nab-paclitaxel as second-line therapy for metastatic pancreati…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors [Phase 1]
Phase 1 trial update on the safety of RAD301 in healthy volunteers and patients with pancreatic ductal adenocarcinoma or other solid tumors;…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Immunoparalysis After Pancreaticoduodenectomy
An ongoing clinical trial in Lyon is recruiting to study immunoparalysis after pancreaticoduodenectomy in patients with pancreatic ductal ad…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection [Phase 2]
Phase 2 trial assessing the imaging tracer 18F-FAPI-74 for cancer detection across multiple indications; currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications [Phase 1, Phase 2]
An ongoing Phase 1/Phase 2 study evaluating an [18F]FPyQCP PET imaging agent targeting fibroblast activation protein across colorectal cance…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance [Phase 2]
A Phase 2 clinical trial evaluating ASP3082 in patients with metastatic or locally advanced non-small cell lung cancer and pancreatic ductal…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer [NA]
This entry reports a recruiting clinical trial investigating circulating tumor DNA (ctDNA) and circular DNA in patients with resectable panc…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer [NA]
This clinical trial outlines a screening program to improve early detection of pancreatic cancer in individuals at high risk and is currentl…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2, Phase 3]
A clinical trial update for a study evaluating Telisotuzumab Adizutecan in combination with FOLFOX versus standard of care as first-line tre…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)
A recruiting clinical trial (VAPOR2) led by Imperial College London studying volatile organic compound assessment in pancreatic cancer/PDAC.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma
Clinical trial update indicating a study evaluating volatile organic compound assessment in pancreatic ductal adenocarcinoma is currently re…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: BBO-11818 in Adult Subjects With KRAS Mutant Cancer [Phase 1]
Phase 1 trial update for BBO-11818 in adults with KRAS-mutant cancers, currently recruiting across several KRAS-driven solid tumors includin…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma [EARLY_Phase 1]
Clinical trial update indicates the investigational agent OMO-103 is being studied in an early-phase trial for locally advanced or metastati…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Fecal Microbial Transplants for the Treatment of Pancreatic Cancer [EARLY_Phase 1]
An early-phase trial is investigating fecal microbiota transplant as a treatment for pancreatic ductal adenocarcinoma and is currently recru…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma [EARLY_Phase 1]
An early-phase trial evaluating cholesterol-disruption in combination with standard of care for advanced pancreatic ductal adenocarcinoma; t…